Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.

Increased Infection Risk in Addison’s Disease and Congenital Adrenal Hyperplasia

Open access

Published version of a preprint

Abstract

Context: Mortality and infection-related hospital admissions are increased in patients with primary adrenal insufficiency (PAI). However, the risk of primary care–managed infections in patients with PAI is unknown. Objective: To estimate infection risk in PAI due to Addison’s disease (AD) and congenital adrenal hyperplasia (CAH) in a primary care setting. Design: Retrospective cohort study using UK data collected from 1995 to 2018. Main outcome measures: Incidence of lower respiratory tract infections (LRTIs), urinary tract infections (UTIs), gastrointestinal infections (GIIs), and prescription counts of antimicrobials in adult PAI patients compared to unexposed controls. Results: A diagnosis of PAI was established in 1580 AD patients (mean age 51.7 years) and 602 CAH patients (mean age 35.4 years). All AD patients and 42% of CAH patients were prescribed glucocorticoids, most frequently hydrocortisone in AD (82%) and prednisolone in CAH (50%). AD and CAH patients exposed to glucocorticoids, but not CAH patients without glucocorticoid treatment, had a significantly increased risk of LRTIs (adjusted incidence rate ratio AD 2.11 [95% confidence interval (CI) 1.64–2.69], CAH 3.23 [95% CI 1.21–8.61]), UTIs (AD 1.51 [95% CI 1.29–1.77], CAH 2.20 [95% CI 1.43–3.34]), and GIIs (AD 3.80 [95% CI 2.99–4.84], CAH 1.93 [95% CI 1.06–3.52]). This was mirrored by increased prescription of antibiotics (AD 1.73 [95% CI 1.69–1.77], CAH 1.77 [95% CI 1.66–1.89]) and antifungals (AD 1.89 [95% CI 1.74–2.05], CAH 1.91 [95% CI 1.50–2.43]). Conclusions: There is an increased risk of infections and antimicrobial use in PAI in the primary care setting at least partially linked to glucocorticoid treatment. Future studies will need to address whether more physiological glucocorticoid replacement modes could reduce this risk.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/clinem/dgz006

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. Forest plot of outcomes. Panel A: Adjusted incidence rate ratio (aIRR) for infections and antimicrobial prescriptions in Addison’s disease (AD) and congenital adrenal hyperplasia (CAH) cohorts. Panel B: aIRR for infections and antimicrobial prescriptions in CAH patients separately for patients with and without chronic glucocorticoid treatment.
Figure 1. Forest plot of outcomes. Panel A: Adjusted incidence rate ratio (aIRR) for infections and antimicrobial prescriptions in Addison’s disease (AD) and congenital adrenal hyperplasia (CAH) cohorts. Panel B: aIRR for infections and antimicrobial prescriptions in CAH patients separately for patients with and without chronic glucocorticoid treatment.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 31 references

Cited by

See all 65

Metadata

Authors
Tresoldi, A. S., Sumilo, D., Perrins, M., Toulis, K. A., Prete, A., Reddy, N., Wass, J. A. H., Arlt, W., & Nirantharakumar, K.
Affiliations
  • IRCCS Humanitas Research Hospital (IT)
  • Institute of Applied Health Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK
  • University of Birmingham (GB)
  • Leicester Royal Infirmary (GB)
  • Churchill Hospital (GB)
  • University Hospitals Birmingham NHS Foundation Trust (GB)
Corresponding author
Arlt, Wiebke
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2019-09-18
Volume
105
Issue
2
Pages
418-429
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W2973526830
Cited by
65
References
31
Citations by year
2026: 7 · 2025: 3 · 2024: 6 · 2023: 11 · 2022: 12 · 2021: 18 · 2020: 8
FWCI
7.71
Type
journal article
Language
en
Open access
Locations
  • The Journal of Clinical Endocrinology & Metabolism (publishedVersion, cc-by)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • University of Birmingham Research Portal (University of Birmingham) (submittedVersion, cc-by)
  • Spiral (Imperial College London) (submittedVersion, cc-by)
Funders
  • Medical Research Council (0900567)
  • UK Research and Innovation
  • Health Data Research
  • National Institute of Health Research
  • Birmingham Biomedical Research Centre
  • Department of Health and Social Care UK
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
  • Life Sciences › Immunology and Microbiology › Immunology › Immunodeficiency and Autoimmune Disorders
  • Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
Keywords
Addison's disease, congenital adrenal hyperplasia, infection risk, lower respiratory tract infection, urinary tract infection, gastrointestinal infections, glucocorticoid therapy, cortisol, prednisolone, antimicrobial prescribing, antifungal prescribing, primary care, immunosuppression
MeSH terms
Addison Disease, Adrenal Hyperplasia, Congenital, Adult, Disease Susceptibility, Female, Glucocorticoids, United Kingdom, Humans, Infections, Male, Middle Aged, Primary Health Care, Retrospective Studies, Risk Factors, Incidence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Increased Infection Risk in Addison’s Disease and Congenital Adrenal Hyperplasia. https://app.cochat.ai/papers/10.1210/clinem/dgz006
The paper
Tresoldi, A. S., Sumilo, D., Perrins, M., Toulis, K. A., Prete, A., Reddy, N., Wass, J. A. H., Arlt, W., & Nirantharakumar, K. (2020). Increased Infection Risk in Addison’s Disease and Congenital Adrenal Hyperplasia. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgz006

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.